SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders

Continues to Recommend Stockholders Vote “FOR” Pending Merger ISS has Dismissed Madryn’s Misleading Claims and Reaffirms that Stockholders Vote “FOR” the Merger BOULDER, Colo., Dec. 29, 2023 /PRNewswire/ — SomaLogic, Inc. (Nasdaq: SLGC) (“the Company”), a leader in proteomics technology,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.